Xylem Inc. current report, 22 June 2020

Xylem Inc. Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by Xylem Inc. on June 22, 2020. The report details a material definitive agreement entered into on the same date regarding the company's credit facilities.

Key Financial Metrics and Debt Structure

The filing does not provide specific revenue, profit, cash flow, or margin figures. The primary financial disclosure concerns the modification of the company's Five-Year Revolving Credit Facility Agreement (originally dated March 5, 2019). The amendment alters the financial covenant testing methodology and imposes restrictions on capital allocation.

Material Changes

  • Covenant Modification: The financial covenant test was changed from a "maximum leverage ratio" (consolidated total debt to consolidated EBITDA) to a "net leverage ratio" (consolidated total debt less unrestricted cash and cash equivalents to consolidated EBITDA).
  • Duration of Change: This net leverage ratio test applies through the quarter ending September 30, 2021. After this date, the covenant reverts to the prior maximum leverage ratio test.
  • Stock Repurchase Restriction: The company is restricted from repurchasing common stock until March 31, 2021. An exception exists for shares issued after the amendment date, subject to customary exceptions.

Outlook, Risks, and Management Commentary

The filing does not contain forward-looking guidance, management commentary on operational outlook, or specific risk factors beyond the implications of the credit facility amendment. The amendment suggests a strategic adjustment to liquidity management and leverage metrics, likely in response to prevailing market conditions or lender requirements.

Investor Verification Checklist

  • Verify the exact terms of the "net leverage ratio" calculation in the full text of Amendment No. 1 (Exhibit 10.34.1).
  • Confirm the current levels of unrestricted cash and cash equivalents to assess the impact of the new covenant test.
  • Review the company's capital allocation strategy post-March 31, 2021, given the temporary suspension of stock repurchases.
  • Monitor future filings for the reversion to the maximum leverage ratio test after September 30, 2021.